Retinoic acid‐induced expression of the CD38 ectoenzyme receptor in HL‐60 human
myeloblastic leukemia cells is regulated by RARα and RXR, and enhanced or prevented cell …

The lymphocyte cell surface antigen CD38, which was originally described as a
differentiation marker, has emerged as an important multifunctional protein. Its most …

CD38 is a leukocyte differentiation antigen that has been thought to be a phenotypic marker
of different subpopulations of T-and B-lymphocytes. In myeloid cells, CD38 is expressed …

Human leukocyte antigen CD38, a 45-kD single-chain, transmembrane glycoprotein, is a
bifunctional ectoenzyme that participates in signal transduction pathways involved in the …

The CD38 or T10 molecule is one of the least understood differentiation antigens. Virtually
no information is available on the regulation and functions of CD38 antigen in hematopoietic …

ABSTRACT ATRA and a synthetic RAR agonist tamibarotene (Am80) induce granulocytic
differentiation of human acute leukemia HL-60 cells and have been used in antineoplastic …

The cell surface antigen, CD38, is a 45-kDa transmembrane protein which is predominantly
expressed on hematopoietic cells during differentiation. As a bifunctional ectoenzyme, it …

Several signaling pathways are activated by all-trans-retinoic acid (RA) to mediate induction
of differentiation and apoptosis of malignant cells. In the present study we provide evidence …

Human CD38 antigen, a 45-kDa type II cell-surface glycoprotein, was initially described by
immunologists as a lymphoid-cell differentiation marker [1]. A subsequent report that the …

All‐trans retinoic acid (ATRA) is a specific inducer of CD38 antigen on marrow CD34+ cells
as well as on blast cells in acute promyelocytic and myeloblastic leukaemia. The CD38 …